New ‘discreet’ Viagra Launched ending Embarrassment Of Blue Pill
The makers of Viagra are set to introduce a brand-new ‘discrete’ kind of the drug that will replace the iconic – and quickly recognisable – little blue tablet.
The distinct diamond-shaped tablets might soon be replaced by a pink, rectangular ‘wafer’ that dissolves on the tongue, indicating it does not require to be taken with water.
About half of males over 40 suffer erectile dysfunction in the UK and in 2015 there was a record 4.57 million prescriptions for Viagra on the NHS.
The drug first came to the marketplace in the 1990s after being created by the American pharmaceutical business Pfizer.
It was first established in the 1980s as a cardiovascular disease medication, but trial participants discovered it had an unusual side result – regular erections.
Now, Pfizer spin-off Viatris, which owns the Viagra name and brand name, has actually requested a trademark in the UK for the brand-new type of the drug, Viagra ODF.
Viatris has currently released the Viagra ODF in Canada and advertised it as being ‘thin and discreet’ which may be more suitable for numerous consumers.
The distinct tablets – which can cause embarrassment for some patients – has been reinvented and a brand-new dissolvable type might be offered to Brits in the next 5 years. Stock image
‘Tablets are not constantly bearable to patients and also often the size of tablets might put clients off having them,’ Thorrun Govind, pharmacist and health specialist, told The Telegraph.
She included: ‘Some males might still be discovering the idea of having Viagr awkward, but I would hope that men’s health and discussions about sexual health have carried on since Viagra was very first developed.’
Ms Govind thinks this brand-new design is a ‘positive advance’.
The new dissolvable medication is believed to most likely concerned the UK imminently.
Rebecca Anderson-Smith, partner and chartered trade mark lawyer at Mewburn Ellis, informed the paper that the hallmark application is a ‘great indication’ it will be available within the next five years.
She described trade mark registrations can be cancelled if they are not used for a constant period of five years or more after registration. As an outcome, it seems Viatris intends to launch the product within the next few years.
However, approving a hallmark would not guarantee the ODF could be offered and it would need to be approved by the Medicines & Healthcare products Regulatory Agency initially.
It’s anticipated to cost the exact same as the tablet variation and to be offered in the same dosages.
A total of 4.57 million prescriptions for sildenafil, more frequently understood by the brand name Viagra, and other kinds of impotency drugs offered under the brand Cialis and Levitra, were dispensed by the health service in 2023
This comes after dodgy Viagra was found to be Britain’s biggest counterfeit drug after more than ₤ 6.2 countless phony blue tablet were taken by UK regulators in 2023.
More materials of the erectile dysfunction drug were discovered than knock-off versions of painkillers like morphine.
Health authorities said online regulations were behind the counterfeit products with most being imported from nations like India without a proper licence.
Data, from UK regulator The Medicines and Healthcare products Regulatory Agency (MHRA), show 2.6 million dosages of sildenafil, the generic name for the medication best referred to as Viagra, were taken last year.
Another half-million doses of tadalafil, another erectile dysfunction drug sold under the brand Cialis worth ₤ 1.2 million were also taken.
While all medications carry prospective adverse effects drugs from undependable sources may either not work or bring extra active ingredients or contaminants like heavy metals or other drugs that could be unsafe.
